Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
002675.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | CN¥659,377 | CN¥696,784 | CN¥686,928 | CN¥706,505 |
| % Growth | -5.4% | 1.4% | -2.8% | – |
| Cost of Goods Sold | CN¥276,834 | CN¥366,272 | CN¥375,506 | CN¥343,741 |
| Gross Profit | CN¥382,543 | CN¥330,511 | CN¥311,422 | CN¥362,763 |
| % Margin | 58% | 47.4% | 45.3% | 51.3% |
| R&D Expenses | CN¥67,588 | CN¥50,737 | CN¥44,008 | CN¥145,045 |
| G&A Expenses | CN¥0 | CN¥59,782 | CN¥89,592 | CN¥95,524 |
| SG&A Expenses | CN¥199,682 | CN¥170,118 | CN¥186,081 | CN¥197,416 |
| Sales & Mktg Exp. | CN¥0 | CN¥110,336 | CN¥96,489 | CN¥101,892 |
| Other Operating Expenses | CN¥11,905 | CN¥31,332 | CN¥46,042 | CN¥15,316 |
| Operating Expenses | CN¥279,176 | CN¥252,187 | CN¥276,132 | CN¥357,776 |
| Operating Income | CN¥103,367 | CN¥78,324 | CN¥35,291 | CN¥4,987 |
| % Margin | 15.7% | 11.2% | 5.1% | 0.7% |
| Other Income/Exp. Net | -CN¥33,790 | -CN¥1,087 | -CN¥439 | -CN¥306 |
| Pre-Tax Income | CN¥69,577 | CN¥77,237 | CN¥34,851 | CN¥4,681 |
| Tax Expense | CN¥15,061 | CN¥24,348 | CN¥17,702 | CN¥14,913 |
| Net Income | CN¥60,463 | CN¥63,921 | CN¥24,732 | CN¥16,958 |
| % Margin | 9.2% | 9.2% | 3.6% | 2.4% |
| EPS | 0.073 | 0.078 | 0.03 | 0.021 |
| % Growth | -5.4% | 158.3% | 45.6% | – |
| EPS Diluted | 0.073 | 0.078 | 0.03 | 0.021 |
| Weighted Avg Shares Out | 824,596 | 824,596 | 824,384 | 824,596 |
| Weighted Avg Shares Out Dil | 824,596 | 824,596 | 824,384 | 824,596 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥2,552 | CN¥18,525 | CN¥3,166 | CN¥1,808 |
| Interest Expense | CN¥81,210 | CN¥0 | CN¥27,745 | CN¥28,662 |
| Depreciation & Amortization | CN¥0 | CN¥43,670 | CN¥37,520 | CN¥37,520 |
| EBITDA | CN¥155,403 | CN¥152,829 | CN¥90,961 | CN¥46,561 |
| % Margin | 23.6% | 21.9% | 13.2% | 6.6% |